|
|
Article: ESTORRA(TM) One-Year Data Presented At Associated Professional Sleep Societies Meeting.
- Article from:
- PR Newswire
- Article date:
- June 9, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sepracor Inc. today announced the presentation of data from the first successful, long-term, placebo-controlled study conducted with a non-benzodiazepine for the treatment of chronic insomnia. Data from this large-scale study of eszopiclone in which patients 21-69 years of age received nightly treatment of either placebo (n=195) or eszopiclone 3 mg (n=593) were presented at the annual meeting of the Associated Professional Sleep Societies (APSS) in Chicago. The study was designed to evaluate safety and efficacy over 12 months of treatment: the first six months of the study were placebo- controlled and the second six months were open-label. In this study, subjective ...
Related newspaper, magazine, and journal articles:
|
|
Article: Given the therapeutic effect of shouting 'waaaaa' ...
The Independent - London;
January 6, 1996 ;
700+ words
... ... likely to succumb to certain illnesses, thus would not require expensive treatment. In that case, given the therapeutic effect of shouting "waaaa" at football matches, perhaps season tickets could be made available on prescription too ...
|
|